- Home
- CNMD vs ATRC Comparison
CNMD vs ATRC Comparison
Compare CNMD & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- ATRC
- Stock Information
- Founded
- CNMD 1970
- ATRC 2000
- Country
- CNMD United States
- ATRC United States
- Employees
- CNMD N/A
- ATRC N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATRC Medical/Dental Instruments
- Sector
- CNMD Health Care
- ATRC Health Care
- Exchange
- CNMD Nasdaq
- ATRC Nasdaq
- Market Cap
- CNMD 1.5B
- ATRC 1.7B
- IPO Year
- CNMD 1987
- ATRC 2005
- Fundamental
- Price
- CNMD $44.00
- ATRC $34.55
- Analyst Decision
- CNMD Hold
- ATRC Strong Buy
- Analyst Count
- CNMD 5
- ATRC 9
- Target Price
- CNMD $59.80
- ATRC $52.00
- AVG Volume (30 Days)
- CNMD 341.7K
- ATRC 510.4K
- Earning Date
- CNMD 11-05-2025
- ATRC 10-29-2025
- Dividend Yield
- CNMD 1.82%
- ATRC N/A
- EPS Growth
- CNMD 12.82
- ATRC N/A
- EPS
- CNMD 3.54
- ATRC N/A
- Revenue
- CNMD $1,326,244,000.00
- ATRC $518,304,999.00
- Revenue This Year
- CNMD $6.73
- ATRC $16.32
- Revenue Next Year
- CNMD $5.45
- ATRC $12.37
- P/E Ratio
- CNMD $12.43
- ATRC N/A
- Revenue Growth
- CNMD 3.94
- ATRC 15.80
- 52 Week Low
- CNMD $42.50
- ATRC $28.29
- 52 Week High
- CNMD $78.00
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- CNMD 36.37
- ATRC 41.20
- Support Level
- CNMD $43.64
- ATRC $30.94
- Resistance Level
- CNMD $48.19
- ATRC $37.28
- Average True Range (ATR)
- CNMD 1.49
- ATRC 1.63
- MACD
- CNMD -0.00
- ATRC -0.28
- Stochastic Oscillator
- CNMD 17.96
- ATRC 48.30
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.